Clinical Trial Update: Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pre-operative atezolizumab in resectable HPV-related oropharyngeal cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-related Oropharyngeal Cancer
• Oropharyngeal Cancer

Drugs mentioned

• Tecentriq (atezolizumab) (atezolizumab)

Snippet

Sponsor: Emory University | Conditions: Oropharynx Cancer, Stage I | Phase 2 | Status: SUSPENDED